Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of N1539 (Anjeso) in Major Surgery
NCT02720692Phase 3Completed
- Sponsor
- Baudax Bio
- Start
- Mar 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of Anjeso in postoperative pain, sponsored by Baudax Bio. Started Mar 2016; status: completed.
02
Drugs
Anjeso
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02720692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02720692.